Nanjing Tianzong Yikang Biotechnology Co., Ltd. (abbreviated as Tianzong Biology), founded in September 2012 and headquartered in the Biopharmaceutical Valley of Nanjing High-tech Zone, is a modern high-tech biotechnology enterprise integrating R&D, production, marketing, and services. The company focuses on the fields of biological tissue engineering materials and minimally invasive diagnosis and treatment, and is committed to the R&D and industrialization of biotechnology.
The company has established technical platforms for hyaluronic acid, nanogold colloid, immunofluorescence, latex turbidimetry, chemiluminescence, and instrument development, and is additionally building a molecular diagnostics platform and an antigen and antibody raw material R&D platform. Currently, more than 20 products have been launched on the market, and another 30-plus new products are under R&D and registration. The products cover multiple fields including skin and mucosa, soft tissue and hard tissue injury repair, rapid detection of acute injuries to major organs such as the heart and kidneys, and metabolic diseases such as diabetes. At the same time, Tianzong Biology has launched a health cloud service platform integrating "software + hardware + services," embarking on a new journey in internet healthcare. Serving tiered diagnosis and treatment and chronic disease management models, it utilizes internet and IoT technologies to achieve one-stop industrialized health services combining "medical service cloud," "health management cloud," and "home life cloud."
The company emphasizes technological progress and innovation and has built a modern R&D and testing center covering 4,000 square meters, introducing high-tech R&D and testing equipment. It has obtained one national invention patent, 20 national utility model patents, and 6 international patents, with more than 40 invention patents under application. It has obtained 22 Class II medical device product certificates, demonstrating high innovativeness, and more than 20 other products are under registration and approval.
The company gathers a group of talents with career dreams who, with firm belief, down-to-earth effort, and pioneering spirit, make unremitting efforts and strive to "let more people live better." Since its establishment, it has successively received multiple honorary titles such as "National High-tech Enterprise," "Jiangsu Private Technology Enterprise," "Jiangsu Outstanding Enterprise," and "Jiangsu Integrity Enterprise." Several strategic investment institutions have invested in the company. In November 2015, the company was officially listed on the New Third Board (securities name: Tianzong Biology, securities code: 834258).
Looking to the future, the company will focus on in-depth R&D of core technologies in the fields of biological tissue engineering materials and minimally invasive diagnosis and treatment, to create more high-quality products! Tianzong people will surely practice through their actions, applying leading technology, pursuing high-end quality, integrating humanistic care, and serving the health cause.
What does Nanjing Tianzong Yikang Biotechnology Co., Ltd. require? Who is Tianzong Biology hiring? Tianzong Biology recruitment: Customer Service占比最多占51.7%,其次是Computer/Network/Technology占37.9%. What education can get in at Tianzong Biology? 大专占比最多占65.5%,其次是本科占27.6%. High education required at Tianzong Biology? 博士占3.4%. Work experience required at Tianzong Biology? 3-5年占比最多占37.9%,其次是1-3年占34.5%. Where are the job locations at Tianzong Biology? 南京占比最多占72.4%,其次是深圳占10.3%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows